1-deoxynojirimycin has been researched along with Acute Coronary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arasaki, O; Dai, K; Ikenaga, H; Inoue, Y; Ishihara, M; Kishimoto, S; Mori, Y; Niki, T; Node, K; Ogasawara, K; Oshiro, K; Sata, M; Shibata, Y; Shimabukuro, M; Takashima, A; Tanaka, A | 1 |
| Chiku, M; Fukamachi, D; Hirayama, A; Hiro, T; Kitano, D; Li, Y; Okumura, Y; Saito, S; Takayama, T | 1 |
2 trial(s) available for 1-deoxynojirimycin and Acute Coronary Syndrome
| Article | Year |
|---|---|
α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study.
Topics: 1-Deoxynojirimycin; Acute Coronary Syndrome; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose; Glycoside Hydrolase Inhibitors; Heart Rate; Humans; Hypoglycemic Agents; Male; Middle Aged; Treatment Outcome | 2017 |
Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia.
Topics: 1-Deoxynojirimycin; Acute Coronary Syndrome; Aged; Case-Control Studies; Endothelium, Vascular; Female; Humans; Hyperglycemia; Hypoglycemic Agents; Male; Manometry; Middle Aged; Percutaneous Coronary Intervention; Postprandial Period; Treatment Outcome | 2013 |